Telomere-mediated lung disease.

Area of Science:

• Pulmonary Medicine
• Genetics
• Cellular Biology

Background:

• Parenchymal lung disease is a significant and increasing cause of mortality in the US.
• Telomeres and telomerase, known for roles in aging and cancer, are now implicated in lung disease etiology.
• Genetic discoveries link telomere and telomerase dysfunction to idiopathic pulmonary fibrosis (IPF) and emphysema.

Purpose of the Study:

• To critically evaluate the progress in understanding the role of telomere abnormalities in lung disease pathogenesis.
• To emphasize how genetic findings provide a new paradigm for age-related lung disease.
• To highlight the link between telomere abnormalities, stem cell senescence, and impaired lung function.

Main Methods:

• Review of genetic discoveries linking telomere maintenance genes to lung diseases.
• Analysis of patient data showing prevalence of short telomeres in IPF.
• Evaluation of clinical implications of telomere dysfunction, including extrapulmonary manifestations.

Main Results:

• Short telomere defect is prevalent in a subset of IPF patients, with germline mutations found in one-third of families with pulmonary fibrosis.
• Half of sporadic IPF patients exhibit short telomere length.
• Short telomeres are associated with T-cell immunodeficiency and myeloid malignancies, indicating syndromic extrapulmonary disease.

Conclusions:

• Telomere dysfunction is a unifying molecular defect in a subset of lung disease patients, offering a precision medicine approach.
• Diagnosis based on telomere-mediated lung disease has greater prognostic value than traditional methods.
• Genetic findings suggest a new pathogenesis paradigm for age-related lung disease involving telomere abnormalities, stem cell senescence, and impaired gas exchange.